A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)

Inclusion Criteria: * Signed and dated informed consent obtained from the subject's parent/guardian. * Chinese male or non-child bearing potential female pediatric outpatients subjects who are \>=2 to \<=12 years of age at Visit 2. * Diagnosis of AR: Subjects must have a diagnosis of intermittent allergy rhinitis (IAR) \[symptoms are present \<4 days a week, or for \<4 weeks\] or persistent allergic rhinitis (PER) \[symptoms are present \>=4 days a week, or for \>=4 weeks\] by symptoms, physical signs skin prick test (SPT) and serum-specific immunoglobulin E (IgE) test. Subjects must have 2 or more symptoms of AR (watery rhinorrhea, nasal obstruction, nasal itching and sneezing), which are also present consecutively or accumulatively more than 1 hour on each day prior to Visit 1, or/and concomitant ocular symptoms: ocular itching, red eyes, watery eyes etc. The physical signs includes: nasal mucosa pale, oedema, nasal secretion. Allergic shiner and allergic crease in severity pediatric. A documented positive prick skin test and a positive serum specific IgE test using standardized allergen extract. A positive skin test is defined as a allergen wheal \>=3 millimeters (mm), a histamine \>=3 mm. Subjects have nasal symptoms described above or/and associated with ocular symptoms, as well as the nasal signs and one of laboratory test positive or demonstrate SPT represented a positive response or serum-specific IgE testing represented a positive response within 12 months prior to …